Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-21

FDA Approved: LEVOTHYROXINE SODIUM — Original Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved the original application for levothyroxine sodium as a generic thyroid hormone replacement product from NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

ORIG AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)